Zhaoke Ophthalmology Limited (6622.HK)

Name: Zhaoke Ophthalmology Limited Financial Statements
Creator: Quarter Results

Healthcare | Biotechnology

Latest reporting period: 2026-04-08

Latest Quarter

2026-04-08

Revenue

$15.8M

Net Income

-$117M

Operating Margin

-1,003.4%

Free Cash Flow

-$298M

Debt / Assets

15.3%

Values are in USD and rounded to the nearest whole number unless noted.

Swipe horizontally to view all columns.

Income statement quarterly history for Zhaoke Ophthalmology Limited (6622.HK).
Income Statement (Quarterly)	2026-04-08	2025-06-30	2025-03-31	2024-12-31
Revenue	15,803,000	15,803,000	7,901,500	9,777,500
Cost of Revenue	7,336,000	7,336,000	3,668,000	5,299,000
Gross Profit	8,467,000	8,467,000	4,233,500	4,478,500
Operating Expenses
R&D Expenses	0	0	0	0
SG&A Expenses	53,980,000	53,980,000	26,990,000	37,289,500
Operating Expenses	167,030,000	167,030,000	83,515,000	118,474,000
Operating Income	-158,563,000	-158,563,000	-79,281,500	-113,995,500
Interest Expense	0	4,340,000	0	0
Income Before Tax	-116,623,000	-116,623,000	-58,311,500	-80,845,500
Income Tax Expense	0	0	0	0
Net Income	-116,623,000	-116,623,000	-58,311,500	-80,845,500
Per Share
EPS	-0.22	-0.22	-0.11	-0.15
EPS Diluted	0.00	0.00	0.00	0.00

Income statement annual history for Zhaoke Ophthalmology Limited (6622.HK).
Income Statement (Annual)	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
Revenue	69,324,000	18,750,000	0	0	0
Cost of Revenue	17,527,000	4,503,000	0	0	0
Gross Profit	51,797,000	14,247,000	0	0	0
Operating Expenses
R&D Expenses	0	0	0	0	0
SG&A Expenses	134,281,000	43,160,000	48,090,000	65,446,000	16,836,000
Operating Expenses	279,788,000	390,814,000	405,006,000	380,298,000	118,057,000
Operating Income	-227,991,000	-376,567,000	-404,175,000	-364,332,000	-118,057,000
Interest Expense	9,502,000	7,921,000	3,142,000	1,949,000	1,655,000
Income Before Tax	-237,493,000	-384,488,000	-407,317,000	-2,129,780,000	-726,981,000
Income Tax Expense	0	550,000	3,142,000	0	0
Net Income	-237,493,000	-385,038,000	-410,459,000	-2,129,780,000	-726,981,000
Per Share
EPS	-0.43	-0.71	-0.76	-3.98	-1.36
EPS Diluted	0.00	0.00	0.00	0.00	0.00

Balance sheet quarterly history for Zhaoke Ophthalmology Limited (6622.HK).
Balance Sheet (Quarterly)	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Assets
Cash and Cash Equivalents	1,121,005,000	1,461,623,000	1,716,351,000	2,128,429,000
Short Term Investments	70,156,000	0	8,873,000	8,157,000
Net Receivables	15,353,000	3,710,000	0	0
Inventory	14,901,000	6,141,000	0	0
Total Current Assets	1,614,912,000	1,794,569,000	1,972,747,000	2,208,894,000
Property Plant Equipment	192,137,000	233,306,000	263,253,000	234,130,000
Goodwill and Intangibles	413,553,000	392,463,000	334,623,000	162,383,000
Total Assets	2,243,515,000	2,420,338,000	2,570,623,000	2,605,407,000
Liabilities
Account Payables	1,169,000	1,166,000	11,051,000	0
Short Term Debt	222,538,000	216,162,000	104,225,000	16,171,000
Total Current Liabilities	313,049,000	336,451,000	194,540,000	89,008,000
Long Term Debt	16,049,000	21,864,000	27,703,000	20,861,000
Total Liabilities	343,438,000	372,020,000	222,250,000	109,920,000
Shareholders Equity
Retained Earnings	-4,034,753,000	-3,806,856,000	-3,429,275,000	0
Total Shareholders Equity	1,900,077,000	2,048,318,000	2,348,373,000	2,495,487,000

Balance sheet annual history for Zhaoke Ophthalmology Limited (6622.HK).
Balance Sheet (Annual)	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
Assets
Cash and Cash Equivalents	1,121,005,000	1,461,623,000	1,716,351,000	2,128,429,000	65,096,000
Short Term Investments	70,156,000	0	8,873,000	8,157,000	806,247,000
Net Receivables	15,353,000	3,710,000	0	0	0
Inventory	14,901,000	6,141,000	0	0	0
Total Current Assets	1,614,912,000	1,794,569,000	1,972,747,000	2,208,894,000	913,623,000
Property Plant Equipment	192,137,000	233,306,000	263,253,000	234,130,000	174,272,000
Goodwill and Intangibles	413,553,000	392,463,000	334,623,000	162,383,000	138,691,000
Total Assets	2,243,515,000	2,420,338,000	2,570,623,000	2,605,407,000	1,226,586,000
Liabilities
Account Payables	1,169,000	1,166,000	11,051,000	0	0
Short Term Debt	222,538,000	216,162,000	104,225,000	16,171,000	14,749,000
Total Current Liabilities	313,049,000	336,451,000	194,540,000	89,008,000	53,666,000
Long Term Debt	16,049,000	21,864,000	27,703,000	20,861,000	22,778,000
Total Liabilities	343,438,000	372,020,000	222,250,000	109,920,000	1,972,554,000
Shareholders Equity
Retained Earnings	-4,034,753,000	-3,806,856,000	-3,429,275,000	0	-892,178,000
Total Shareholders Equity	1,900,077,000	2,048,318,000	2,348,373,000	2,495,487,000	-745,968,000

Cash flow quarterly history for Zhaoke Ophthalmology Limited (6622.HK).
Cash Flow Statement (Quarterly)	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Operating Activities
Net Income	-237,493,000	-384,488,000	-407,317,000	-2,129,780,000
Depreciation & Amortization	53,564,000	48,704,000	35,074,000	25,831,000
Stock Based Compensation	8,665,000	22,023,000	46,684,000	109,858,000
Change in Working Capital	-41,690,000	59,352,000	646,000	2,909,000
Operating Cash Flow	-253,723,000	-323,664,000	-331,050,000	-245,143,000
Investing Activities
Capital Expenditure	-44,070,000	-95,267,000	-238,552,000	-94,492,000
Investments	-10,098,000	-36,467,000	-238,552,000	-65,529,000
Investing Cash Flow	-116,448,000	-75,768,000	-324,568,000	683,521,000
Financing Activities
Debt Repayment	6,028,000	112,077,000	-9,600,000	-400,000
Common Stock Issued/Repurchased	0	1,853,000	1,250,000	1,743,334,000
Dividends Paid	0	0	0	0
Financing Cash Flow	-12,122,000	99,294,000	76,230,000	1,658,515,000
Summary
Free Cash Flow	-297,793,000	-418,931,000	-569,602,000	-339,635,000
Net Change in Cash	-340,618,000	-254,728,000	-412,078,000	2,063,333,000

Cash flow annual history for Zhaoke Ophthalmology Limited (6622.HK).
Cash Flow Statement (Annual)	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
Operating Activities
Net Income	-237,493,000	-384,488,000	-407,317,000	-2,129,780,000	-726,981,000
Depreciation & Amortization	53,564,000	48,704,000	35,074,000	25,831,000	19,853,000
Stock Based Compensation	8,665,000	22,023,000	46,684,000	109,858,000	14,998,000
Change in Working Capital	-41,690,000	59,352,000	646,000	2,909,000	-19,007,000
Operating Cash Flow	-253,723,000	-323,664,000	-331,050,000	-245,143,000	-103,425,000
Investing Activities
Capital Expenditure	-44,070,000	-95,267,000	-238,552,000	-94,492,000	-175,955,000
Investments	-10,098,000	-36,467,000	-238,552,000	-65,529,000	-66,360,000
Investing Cash Flow	-116,448,000	-75,768,000	-324,568,000	683,521,000	-955,483,000
Financing Activities
Debt Repayment	6,028,000	112,077,000	-9,600,000	-400,000	0
Common Stock Issued/Repurchased	0	1,853,000	1,250,000	1,743,334,000	0
Dividends Paid	0	0	0	0	0
Financing Cash Flow	-12,122,000	99,294,000	76,230,000	1,658,515,000	973,687,000
Summary
Free Cash Flow	-297,793,000	-418,931,000	-569,602,000	-339,635,000	-279,380,000
Net Change in Cash	-340,618,000	-254,728,000	-412,078,000	2,063,333,000	-89,673,000